Satellite Symposium - Expert Insights on New Systemic Therapies for Advanced Prostate Cancer
Registration and Breakfast - 7:30 - 8:00 am
Scientific Session - 8:00 - 9:30 am
The clinical management of prostate cancer is evolving rapidly with the emergence of new therapeutic strategies for nonmetastatic castration-resistant prostate cancer and metastatic hormone-sensitive prostate cancer. The use of biomarkers and tumor molecular assays is also changing the way prostate cancer is managed, through better risk stratification and more individualized treatment recommendations. These recent developments pose many challenges for urologists and other healthcare professionals who are involved in the multidisciplinary management of patients with prostate cancer. In this program, a panel of prostate cancer experts will address these challenges reviewing the latest National Comprehensive Cancer Network® (NCCN®) guidelines and supporting evidence while providing their insights for incorporating this information into clinical practice.
Joint Accreditiation Statement:
In support of improving patient care, National Comprehensive Cancer Network (NCCN) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
NCCN designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NCCN designates this educational activity for a maximum of 1.5 contact hours.
NCCN designates this knowledge-based continuing education activity for 1.5 contact hours (0.15 CEUs) of continuing education credit. UAN: JA4008196-9999-19-027-L01-P
NCCN has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Supported by independent educational grants from Astellas and Pfizer Inc.
Register here: Live Event